Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Roivant Sciences Ltd. Director's Dealing 2026

Feb 14, 2026

30587_dirs_2026-02-13_dfc48ae6-c324-4b77-9e8e-649949066450.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Roivant Sciences Ltd. (ROIV)
CIK: 0001635088
Period of Report: 2026-02-11

Reporting Person: Gold Daniel Allen (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2026-02-11 Common Shares S 425000 $26.67 Disposed 15928113 Indirect
2026-02-12 Common Shares S 150000 $26.72 Disposed 15778113 Indirect
2026-02-12 Common Shares S 275000 $26.76 Disposed 15503113 Indirect
2026-02-13 Common Shares S 150784 $26.49 Disposed 15352329 Indirect
2026-02-13 Common Shares S 225000 $26.50 Disposed 15127329 Indirect

Footnotes

F1: The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.